OM
Opaleye Management Inc. disclosed a 8.5% stake in ETON
Opaleye Management Inc. reported owning 8.5% of Eton Pharmaceuticals, Inc. (ETON) (2,440,000 shares) in a Schedule 13G filed Nov 6, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 6, 2026
- Source
- Schedule 13G